Studies on the formation of ribonucleic acid-ribosome complexes. XVI. Effect of ribosomal translocation inhibitors on polyribosomes.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002499:Centrifugation, Density Gradient; D002701:Chloramphenicol / Q000494:pharmacology; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D004926:Escherichia coli / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D005672:Fusidic Acid / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D008954:Models, Biological; D010452:Peptide Biosynthesis; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology; D011691:Puromycin / Q000378:metabolism / Q000494:pharmacology; D012270:Ribosomes / Q000187:drug effects* / Q000378:metabolism; D014316:Tritium
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D003509:Cyclohexanecarboxylic Acids; D010455:Peptides; D014316:Tritium; D011691:Puromycin; D005672:Fusidic Acid; D002701:Chloramphenicol; D007930:Leucine